搜尋結果
2023
2022
respiratory disease
100%
respiratory tract diseases
86%
virus
78%
Fungi
72%
fungus
70%
2021
Yu, W. L. ,
Toh, H. S. ,
Liao, C. T. &
Chang, W. T. ,
2021 ,
於: Acta Cardiologica Sinica. 36 ,
7 ,
p. 9-17 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
SARS Virus
100%
Coronavirus
56%
Viruses
30%
Explosive Agents
28%
Pandemics
24%
Ku, Y. H. ,
Chao, C. M. ,
Ou, H. F. &
Yu, W. L. ,
3月 1 2021 ,
於: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 72 ,
5 ,
p. 899-900 2 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Liu, J. W. ,
Ku, Y. H. ,
Chao, C. M. ,
Ou, H. F. ,
Ho, C. H. ,
Chan, K. S. &
Yu, W. L. ,
3月 2021 ,
於: Journal of Fungi. 7 ,
3 , 227.
研究成果: 雜誌貢獻 › 文章 › 同行評審
aspergillosis
100%
influenza
88%
Aspergillosis
84%
Aspergillus
70%
Taiwan
70%
Chao, C. M. ,
Lai, C. C. ,
Ou, H. F. ,
Ho, C. H. ,
Chan, K. S. ,
Yang, C. C. ,
Chen, C. M. &
Yu, W. L. ,
11月 2021 ,
於: Journal of Fungi. 7 ,
11 , 922.
研究成果: 雜誌貢獻 › 文章 › 同行評審
aspergillosis
100%
influenza
88%
Aspergillosis
84%
Critical Illness
66%
Human Influenza
65%
2020
Chan, K. S. ,
Liang, F. W. ,
Tang, H. J. ,
Toh, H. S. &
Yu, W. L. ,
9月 25 2020 ,
於: Medicina Clinica. 155 ,
6 ,
p. 249-253 5 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Taiwan
100%
Respiratory Tract Infections
93%
Human Influenza
74%
Streptococcus pneumoniae
61%
Pneumonia
49%
Yu, W. L. ,
Lee, N. Y. ,
Wang, J. T. ,
Ko, W. C. ,
Ho, C. H. &
Chuang, Y. C. ,
5月 2020 ,
於: Antibiotics. 9 ,
5 , 231.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Tigecycline
100%
Enterobacteriaceae
59%
Critical Illness
49%
Intraabdominal Infections
48%
Soft Tissue Infections
43%
2019
Tang, H. J. ,
Lai, C. C. ,
Chen, C. C. ,
Zhang, C. C. ,
Weng, T. C. ,
Chiu, Y. H. ,
Toh, H. S. ,
Chiang, S. R. ,
Yu, W. L. ,
Ko, W. C. &
Chuang, Y. C. ,
4月 1 2019 ,
於: Journal of Microbiology, Immunology and Infection. 52 ,
2 ,
p. 273-281 研究成果: 雜誌貢獻 › 文章 › 同行評審
Tigecycline
100%
carbapenemase
98%
Colistin
93%
Amikacin
86%
Doxycycline
84%
Ku, Y. H. ,
Lee, M. F. ,
Chuang, Y. C. &
Yu, W-L. ,
2019 ,
於: Journal of Clinical Medicine. 8 ,
1 ,
p. 8 8 p. , 1.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Enterobacter cloacae
100%
Taiwan
74%
Plasmids
60%
Genes
30%
Cefuroxime
16%
2018
Yu, W. L. ,
Liu, W. L. ,
Chan, K. S. ,
Yang, C. C. ,
Tan, C. K. ,
Tsai, C. L. ,
Chen, C. M. &
Chuang, Y. C. ,
2月 1 2018 ,
於: Journal of Microbiology, Immunology and Infection. 51 ,
1 ,
p. 141-147 研究成果: 雜誌貢獻 › 文章 › 同行評審
Particulate Matter
100%
Aspergillus
93%
Taiwan
81%
Human Influenza
75%
Aspergillosis
49%
Tang, H. J. ,
Chen, C. C. ,
Lai, C. C. ,
Zhang, C. C. ,
Weng, T. C. ,
Chiu, Y. H. ,
Toh, H. S. ,
Chiang, S. R. ,
Yu, W. L. ,
Ko, W. C. &
Chuang, Y. C. ,
2月 1 2018 ,
於: Journal of Microbiology, Immunology and Infection. 51 ,
1 ,
p. 76-81 研究成果: 雜誌貢獻 › 文章 › 同行評審
Vibrio vulnificus
100%
Tigecycline
90%
Cefotaxime
55%
Minocycline
38%
In Vitro Techniques
29%
2017
Tang, H. J. ,
Lai, C. C. ,
Chen, C. C. ,
Zhang, C. C. ,
Weng, T. C. ,
Yu, W. L. ,
Chen, H. J. ,
Chiu, Y. H. ,
Ko, W. C. &
Chuang, Y. C. ,
5月 18 2017 ,
於: Frontiers in Microbiology. 8 ,
MAY , 884.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Cefazolin
100%
Glycopeptides
97%
Cephalosporins
83%
Methicillin-Resistant Staphylococcus aureus
78%
Cefmetazole
40%
Ku, Y. H. ,
Chen, C. C. ,
Lee, M. F. ,
Chuang, Y. C. ,
Tang, H. J. &
Yu, W. L. ,
12月 2017 ,
於: Journal of Microbiology, Immunology and Infection. 50 ,
6 ,
p. 931-939 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Fosfomycin
100%
Tigecycline
98%
Colistin
92%
Carbapenems
84%
Klebsiella pneumoniae
77%
Ku, Y. H. ,
Chan, K. S. ,
Yang, C. C. ,
Tan, C. K. ,
Chuang, Y. C. &
Yu, W. L. ,
9月 2017 ,
於: Journal of the Formosan Medical Association. 116 ,
9 ,
p. 660-670 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Aspergillosis
100%
Coinfection
81%
Human Influenza
77%
Aspergillus
68%
galactomannan
53%
Yu, W. L. ,
Lee, M. F. ,
Chen, C. C. ,
Tang, H. J. ,
Ho, C. H. &
Chuang, Y. C. ,
4月 1 2017 ,
於: Microbial Drug Resistance. 23 ,
3 ,
p. 376-383 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Klebsiella pneumoniae
100%
Bacteremia
96%
Urinary Tract Infections
35%
Genes
30%
Phenotype
22%
Ku, Y. H. ,
Chuang, Y. C. ,
Chen, C. C. ,
Lee, M. F. ,
Yang, Y. C. ,
Tang, H. J. &
Yu, W. L. ,
12月 1 2017 ,
於: Scientific Reports. 7 ,
1 , 6634.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Klebsiella pneumoniae
100%
Meningitis
94%
Microbial Drug Resistance
94%
Virulence
81%
Epidemiology
73%
Kuo, C. C. ,
Yu, W. L. ,
Lee, C. H. &
Wu, N. C. ,
12月 1 2017 ,
於: Medicine (United States). 96 ,
50 , e8949.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Adult-Onset Still's Disease
100%
Constrictive Pericarditis
93%
Salmonella enteritidis
91%
Pericarditis
61%
Pericardium
36%
2016
Tang, H. J. ,
Lai, C. C. ,
Hsueh, P. R. ,
Chen, C. C. ,
Wu, K. Y. ,
Lin, Y. C. ,
Zhang, C. C. ,
Weng, T. C. ,
Chiu, Y. H. ,
Toh, H. S. ,
Chiang, S. R. ,
Yu, W. L. ,
Ko, W. C. &
Chuang, Y. C. ,
6月 1 2016 ,
於: Journal of Microbiology, Immunology and Infection. 49 ,
3 ,
p. 394-401 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
RNA Polymerase II
100%
Rifampin
90%
Methicillin-Resistant Staphylococcus aureus
87%
Mutation
48%
Biofilms
36%
Chen, C. M. ,
Chan, K. S. ,
Cheng, K. C. ,
Chou, W. ,
Chao, H. C. ,
Yeh, C. Y. &
Yu, W. L. ,
12月 2016 ,
於: Journal of Medical Microbiology. 65 ,
12 ,
p. 1505-1511 7 p. , 000388.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Severe Dengue
100%
Bacteremia
76%
Critical Illness
69%
Intensive Care Units
34%
Partial Thromboplastin Time
29%
Chen, C. M. ,
Chan, K. S. ,
Yu, W. L. ,
Cheng, K. C. ,
Chao, H. C. ,
Yeh, C. Y. &
Lai, C. C. ,
8月 1 2016 ,
於: Medicine (United States). 95 ,
31 , e4376.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Severe Dengue
100%
Intensive Care Units
62%
Critical Illness
30%
Dengue
28%
Glasgow Coma Scale
19%
2015
Yeh, P. S. ,
Chen, N. C. ,
Chen, T. Y. ,
Yu, W. L. &
Tang, H. J. ,
8月 1 2015 ,
於: Journal of Internal Medicine of Taiwan. 26 ,
4 ,
p. 227-231 5 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Neurosyphilis
100%
Basilar Artery
84%
Coinfection
66%
HIV
47%
Syphilis
38%
Chen, C. M. ,
Yu, W. L. ,
Huang, M. ,
Liu, J. J. ,
Chen, I. C. ,
Chen, H. F. &
Wu, L. T. ,
9月 1 2015 ,
於: Microbiology and Immunology. 59 ,
9 ,
p. 516-525 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Enterobacter cloacae
100%
Multiple Drug Resistance
78%
Plasmids
60%
Interspersed Repetitive Sequences
26%
Integrons
26%
Yu, W. L. ,
Lee, M. F. ,
Tang, H. J. ,
Chang, M. C. ,
Walther-Rasmussen, J. &
Chuang, Y. C. ,
4月 1 2015 ,
於: Clinical Microbiology and Infection. 21 ,
4 ,
p. 347.e5-347.e8 研究成果: 雜誌貢獻 › 文章 › 同行評審
Taiwan
100%
Disease Outbreaks
89%
Tigecycline
68%
Colistin
64%
Amino Acid Substitution
54%
Chen, C. A. ,
Lin, Z. Z. ,
Yu, W. L. &
Wu, W. S. ,
9月 1 2015 ,
於: Journal of the Formosan Medical Association = Taiwan yi zhi. 114 ,
9 ,
p. 893-894 2 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Cheng, K-C. ,
Lee, M. F. ,
Chuang, Y. C. &
Yu, W. L. ,
4月 1 2015 ,
於: Journal of the Formosan Medical Association. 114 ,
4 ,
p. 379-380 2 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Yu, W. L. ,
Lee, M. F. ,
Chang, M. C. &
Chuang, Y. C. ,
2015 ,
於: Journal of Global Antimicrobial Resistance. 3 ,
2 ,
p. 137-141 5 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Klebsiella pneumoniae
100%
Virulence
81%
Phenotype
56%
Lethal Dose 50
53%
Mutation
52%
Ku, Y. H. ,
Lee, M. F. ,
Chuang, Y. C. ,
Chen, C. C. &
Yu, W. L. ,
12月 1 2015 ,
於: Journal of Microbiology, Immunology and Infection. 48 ,
6 ,
p. 699-702 4 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Colistin
100%
Enterobacteriaceae
86%
Tigecycline
53%
Klebsiella pneumoniae
41%
Enterobacter cloacae
34%
Tang, H. J. ,
Ku, Y. H. ,
Lee, M. F. ,
Chuang, Y. C. &
Yu, W. L. ,
2015 ,
於: BioMed Research International. 2015 , 568079.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Colistin
100%
Imipenem
96%
Carbapenems
70%
Klebsiella pneumoniae
65%
Inoculum
41%
Yu, W. L. ,
Lee, M. F. ,
Tang, H. J. ,
Chang, M. C. &
Chuang, Y. C. ,
4月 1 2015 ,
於: Virulence. 6 ,
2 ,
p. 162-172 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Klebsiella pneumoniae
92%
Virulence
76%
virulence
70%
mutation
59%
phenotype
57%
2014
Wound Infection
100%
Fishes
88%
Hemorrhagic Septicemia
57%
cefpirome
51%
Vibrio vulnificus
48%
Chen, C. M. ,
Cheng, K-C. ,
Chan, K. S. &
Yu, W. L. ,
2014 ,
於: International Journal of Gerontology. 8 ,
1 ,
p. 22-26 5 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Intensive Care Units
100%
Sepsis
97%
Mortality
45%
Critical Illness
28%
Drainage
25%
Chan, K. S. ,
Yang, C. C. ,
Chen, C. M. ,
Yang, H. H. ,
Lee, C. C. ,
Chuang, Y. C. &
Yu, W. L. ,
2014 ,
於: Journal of Critical Care. 29 ,
3 研究成果: 雜誌貢獻 › 文章 › 同行評審
Colitis
100%
Cytomegalovirus
96%
Intensive Care Units
80%
Biopsy
29%
Coloring Agents
16%
2013
Chuang, W. L. ,
Huang, W. P. ,
Chen, M. H. ,
Liu, I. P. ,
Yu, W. L. &
Chin, C. C. ,
11月 2013 ,
於: Journal of Wound, Ostomy and Continence Nursing. 40 ,
6 ,
p. 573-579 7 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Tracheostomy
100%
Randomized Controlled Trials
59%
Skin
48%
Bandages
40%
Pectins
27%
Tang, H. J. ,
Chen, C. C. ,
Cheng, K. C. ,
Wu, K. Y. ,
Lin, Y. C. ,
Zhang, C. C. ,
Weng, T. C. ,
Yu, W. L. ,
Chiu, Y. H. ,
Toh, H. S. ,
Chiang, S. R. ,
Su, B. A. ,
Ko, W. C. &
Chuang, Y. C. ,
11月 2013 ,
於: Antimicrobial Agents and Chemotherapy. 57 ,
11 ,
p. 5717-5720 4 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Rifampin
100%
Methicillin-Resistant Staphylococcus aureus
96%
Biofilms
92%
Fusidic Acid
46%
Fosfomycin
43%
Chuang, Y. C. ,
Lee, M. F. &
Yu, W. L. ,
10月 2013 ,
於: Infection. 41 ,
5 ,
p. 1041-1044 4 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Miliary Tuberculosis
100%
Cytomegalovirus Infections
75%
Cytomegalovirus
45%
Intensive Care Units
38%
Ganciclovir
28%
Su, S. H. &
Yu, W-L. ,
2013 ,
於: 感染控制雜誌. 23 ,
3 ,
p. 135-143 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Cytomegalovirus Infections
100%
Critical Illness
84%
Cytomegalovirus
30%
Pneumonia
24%
Antiviral Agents
17%
Miliary Tuberculosis
100%
Cytomegalovirus Infections
75%
Cytomegalovirus
45%
Intensive Care Units
38%
Ganciclovir
28%
2011
Chou, D. W. ,
Wu, S. L. ,
Lee, C. T. ,
Tai, F. T. &
Yu, W. L. ,
2011 ,
於: Japanese Journal of Infectious Diseases. 64 ,
6 ,
p. 520-524 5 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Bacteremia
100%
Intensive Care Units
81%
Anti-Bacterial Agents
38%
Chryseobacterium
32%
Cefepime
26%
Tang, H. J. ,
Ko, W. C. ,
Chen, C. C. ,
Chen, P. L. ,
Toh, H. S. ,
Weng, T. C. ,
Yu, W. L. ,
Chiang, S. R. &
Chuang, Y. C. ,
6月 2011 ,
於: Antimicrobial Agents and Chemotherapy. 55 ,
6 ,
p. 2755-2759 5 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Tigecycline
100%
Ceftriaxone
85%
Salmonella
76%
In Vitro Techniques
32%
Ciprofloxacin
22%
Tang, H. J. ,
Chen, C. C. ,
Ko, W. C. ,
Yu, W. L. ,
Chiang, S. R. &
Chuang, Y. C. ,
7月 2011 ,
於: International Journal of Antimicrobial Agents. 38 ,
1 ,
p. 46-51 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Methicillin
100%
Vancomycin
87%
Anti-Infective Agents
84%
Biofilms
81%
Linezolid
74%